Overview

Amisulpride in Schizophrenic Acute Phase Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To collect the safety and response of using Amisulpride in acute schizophrenic patients
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Amisulpride
Sulpiride
Sultopride